Platelet Reprogramming in Human Obesity and Diabetes

人类肥胖和糖尿病中的血小板重编程

基本信息

  • 批准号:
    8464247
  • 负责人:
  • 金额:
    $ 62.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-05-01 至 2017-04-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY (See instructions): Cardiovascular disease continues to be the primary cause of morbidity and mortality in North America. The risk of premature atherosclerosis and platelet-dependent cardiovascular events rises with increasing obesity. Complicating this observation is that not all individuals with elevated BMI go on to develop athero-thrombotic disease. We measured expression of 48 genes by high-throughput quantitative reverse transcription PCR in over 2250 participants of the Framingham Offspring and Omni minority cohorts (FHS) using RNA from isolated platelets and found that specific mitochondrial transcripts were significantly and specifically associated with higher body mass index. To determine if there were associated changes in platelet function, we studied select platelet transcripts and function from individuals after short term triglyceride emulsion infusion (acute effect) and identified similar alterations in platelet transcripts that associated with changes in platelet activation. Thus, the central hypothesis of this project is: In the setting of obesity, the human platelet is reprogrammed as seen by altered platelet RNA, including mitochondrial transcripts, and these changes lead to a prothrombotic phenotype that influences the development of athero-thrombotic disease. The effect of obesity on the human platelet as seen in its transcript profile and platelet function will be studied as follows: Aim 1. Characterize the molecular signature of platelets in the setting of increased BMI and determine if it is caused by short term fat intake or chronic obesity and if the changes are reversible with weight loss. Aim 2. Determine the mechanism by which platelet reprogramming alters platelet function including the role of the mitochondria. Aim 3. Determine if platelet reprogramming correlates with subclinical cardiovascular disease (CVD) and the development of clinical CVD. This information along with transcripts from Projects 1-3 and proteins screened in Aim 1 will establish a biomarker panel identifying individuals with elevated BMI at high risk for athero-thrombotic disease. This project seeks not only to define the mechanism by which platelet reprogramming alters function but will determine the human relevance and develop a transcript-based profile.
项目总结(见说明): 心血管疾病仍然是北美发病率和死亡率的主要原因。过早动脉粥样硬化和血小板依赖性心血管事件的风险随着肥胖的增加而增加。 使这一观察结果复杂化的是,并非所有BMI升高的个体都会发展为动脉粥样硬化血栓性疾病。我们使用来自分离血小板的RNA,通过高通量定量逆转录PCR测量了超过2250名Frachial Offspring和Omni minority cohort(FHS)参与者中48个基因的表达,发现特定的线粒体转录物与较高的体重指数显着相关。为了确定血小板功能是否有相关的变化,我们研究了短期甘油三酯乳剂输注(急性效应)后个体的血小板转录物和功能,并确定了与血小板功能变化相关的血小板转录物的类似改变。 血小板活化因此,该项目的中心假设是:在肥胖症的背景下,人类血小板被重新编程,如通过改变的血小板RNA所看到的,包括线粒体转录物,并且这些变化导致影响动脉粥样硬化血栓形成疾病的发展的血栓形成前表型。将研究肥胖对人血小板的影响,如在其转录谱和血小板功能中所见, 目标1.表征BMI增加情况下血小板的分子特征,并确定它是否由短期脂肪摄入或慢性肥胖引起,以及这些变化是否随着体重减轻而可逆。目标2.确定血小板重编程改变血小板功能的机制,包括线粒体的作用。目标3。确定血小板重编程是否与亚临床心血管疾病(CVD)和临床CVD的发展相关。该信息沿着来自项目1-3的转录物和目标1中筛选的蛋白质将建立生物标志物组,其鉴定具有升高的BMI的个体处于动脉粥样硬化血栓性疾病的高风险。该项目不仅旨在确定血小板重编程改变功能的机制,而且还将确定人类相关性并开发基于转录的概况。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew S Weyrich其他文献

DECREASED TRANSENDOTHELIAL CELL MIGRATION IN NEONATES IS ASSOCIATED WITH DELAYED EXPRESSION OF P-SELECTION. ▴ 1754
  • DOI:
    10.1203/00006450-199604001-01778
  • 发表时间:
    1996-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Michael K Garyer;Andrew S Weyrich;Wenhua Li;Diane E Lorant
  • 通讯作者:
    Diane E Lorant

Andrew S Weyrich的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew S Weyrich', 18)}}的其他基金

Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
疾病中巨核细胞和血小板基因表达的转化控制
  • 批准号:
    10616557
  • 财政年份:
    2019
  • 资助金额:
    $ 62.26万
  • 项目类别:
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
疾病中巨核细胞和血小板基因表达的转化控制
  • 批准号:
    10569253
  • 财政年份:
    2019
  • 资助金额:
    $ 62.26万
  • 项目类别:
2014 Hemostasis Gordon Research Conference and Gordon Research Seminar
2014止血戈登研究会议暨戈登研究研讨会
  • 批准号:
    8784662
  • 财政年份:
    2014
  • 资助金额:
    $ 62.26万
  • 项目类别:
Patient Enrollment and Data Analysis
患者登记和数据分析
  • 批准号:
    8464249
  • 财政年份:
    2013
  • 资助金额:
    $ 62.26万
  • 项目类别:
Administrative
行政的
  • 批准号:
    8391960
  • 财政年份:
    2012
  • 资助金额:
    $ 62.26万
  • 项目类别:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
重编程血小板:代谢综合征中血栓形成的效应器
  • 批准号:
    9068226
  • 财政年份:
    2012
  • 资助金额:
    $ 62.26万
  • 项目类别:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
重编程血小板:代谢综合征中血栓形成的效应器
  • 批准号:
    8464229
  • 财政年份:
    2012
  • 资助金额:
    $ 62.26万
  • 项目类别:
Platelet Reprogramming in Human Obesity and Diabetes
人类肥胖和糖尿病中的血小板重编程
  • 批准号:
    8391959
  • 财政年份:
    2012
  • 资助金额:
    $ 62.26万
  • 项目类别:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
重编程血小板:代谢综合征中血栓形成的效应器
  • 批准号:
    8656415
  • 财政年份:
    2012
  • 资助金额:
    $ 62.26万
  • 项目类别:
Human and Mouse Cell Isolation and Phenotyping
人类和小鼠细胞分离和表型分析
  • 批准号:
    8391963
  • 财政年份:
    2012
  • 资助金额:
    $ 62.26万
  • 项目类别:

相似国自然基金

相似海外基金

New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
  • 批准号:
    23K16058
  • 财政年份:
    2023
  • 资助金额:
    $ 62.26万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
  • 批准号:
    23K10969
  • 财政年份:
    2023
  • 资助金额:
    $ 62.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
  • 批准号:
    10751284
  • 财政年份:
    2023
  • 资助金额:
    $ 62.26万
  • 项目类别:
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
  • 批准号:
    23K19518
  • 财政年份:
    2023
  • 资助金额:
    $ 62.26万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
  • 批准号:
    23K18303
  • 财政年份:
    2023
  • 资助金额:
    $ 62.26万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
  • 批准号:
    23H03065
  • 财政年份:
    2023
  • 资助金额:
    $ 62.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
  • 批准号:
    23K05107
  • 财政年份:
    2023
  • 资助金额:
    $ 62.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
  • 批准号:
    10655793
  • 财政年份:
    2023
  • 资助金额:
    $ 62.26万
  • 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
  • 批准号:
    23K05594
  • 财政年份:
    2023
  • 资助金额:
    $ 62.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterizing breast cancer invasion and proliferation when co-aggregated with adipocytes in multicellular spheroids created with a custom bioreactor to augment cell-cell connectivity.
当与多细胞球体中的脂肪细胞共聚集时,表征乳腺癌的侵袭和增殖,该多细胞球体是用定制生物反应器创建的,以增强细胞间的连接。
  • 批准号:
    10334113
  • 财政年份:
    2022
  • 资助金额:
    $ 62.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了